Innate difference in the endocannabinoid signaling and its modulation by alcohol consumption in alcohol-preferring sP rats

Blockade of the Cannabinoid CB1 Receptor and Alcohol Dependence: Preclinical Evidence and Preliminary Clinical Data

(2012) Paola Maccioni et al.   CNS & Neurological Disorders-Drug Targets

Modulation of Brain Endocannabinoid Levels by Voluntary Alcohol Consumption in Alcohol-Preferring AA Rats

(2009) Hanna Malinen et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

CB1 Receptor Blockade Decreases Ethanol Intake and Associated Neurochemical Changes in Fawn-Hooded Rats

(2009) Teresa Femenía et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Central and peripheral consequences of the chronic blockade of CB1cannabinoid receptor with rimonabant or taranabant

(2009) Elena Martín-García et al.   JOURNAL OF NEUROCHEMISTRY

Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides

(2009) K. Yaragudri Vinod et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Rimonabant (SR141716) has no effect on alcohol self-administration or endocrine measures in nontreatment-seeking heavy alcohol drinkers

(2009) David Ted George et al.   PSYCHOPHARMACOLOGY

Cannabinoid Receptor 1 Blocker Rimonabant (SR 141716) for Treatment of Alcohol Dependence

(2008) Michael Soyka et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Genetic and pharmacological manipulations of the CB1 receptor alter ethanol preference and dependence in ethanol preferring and nonpreferring mice

(2008) K. Yaragudri Vinod et al.   SYNAPSE

Time dependent alterations on tyrosine hydroxylase, opioid and cannabinoid CB1 receptor gene expressions after acute ethanol administration in the rat brain

(2007) José M. Oliva et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY